Finance
FTSE 100 closes at record high on rate cut bets; AstraZeneca shines
Published by Global Banking and Finance Review
Posted on November 11, 2025
Global Banking and Finance Review
Company
Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
Published by Global Banking and Finance Review
Posted on November 11, 2025
By Utkarsh Hathi
(Reuters) -Britain's FTSE 100 closed at a record high for the second straight session on Tuesday, as weak UK labour market data boosted hopes for Bank of England rate cuts and drugmaker AstraZeneca hit an all-time high.
The blue-chip index ended up 1.2% at 9,899.6 points, while the mid-cap FTSE 250 gained 0.8%.
AstraZeneca rose 2.6% to solidify its position as Britain's largest listed stock by market value, building on momentum from last week's forecast-beating quarterly results.
Expectations for a BoE rate cut in December were bolstered by clear signs of cooling in Britain's labour market, with unemployment increasing to 5%, the highest in four years, and wage growth continued to slow.
"There's more slack building in the labour market - and perhaps more so than assumed by the MPC (the BoE's Monetary Policy Committee) in its November projections; and two, pay momentum continues to slow. Both should be encouraging for the MPC," said Deutsche Bank's chief economist Sanjay Raja.
The pound initially fell against the dollar following the data, before stabilising to trade nearly flat.
In equities, the pharma and healthcare indexes both gained more than 2.5%, as AstraZeneca was joined by GSK rising 3%, while consumer healthcare group Haleon climbed 3.2%.
Among energy companies, Shell rose 2.2% to its highest in more than a year, while BP gained 2.6%, buoyed by higher oil prices due to U.S. sanctions on Russian oil.
Vodafone jumped 8.3% to a more-than two-year high after a strong performance in Germany helped the company to raise its annual profit forecast and lift dividends for the first time in eight years.
Scientific tools maker Oxford Instruments surged 14.9%, its biggest single-day gain in nearly four years, on improved order momentum.
On the downside, food supplier Hilton Food slumped 22.7% to a ten-year low after it warned that profit growth was likely to be challenging in the next financial year.
(Reporting by Utkarsh Tushar Hathi in Bengaluru. Editing by Vijay Kishore and Mark Potter)